Anika Therapeutics announces $30 million accelerated share repurchase
Anika Therapeutics announced that it will enter into an accelerated share repurchase program to repurchase $30 million of its outstanding common stock. The Company will enter into an accelerated stock repurchase agreement with Morgan Stanley pursuant to a Fixed Dollar Accelerated Share Repurchase. May 23, 2018